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The p-cells of the pancreas control the blood levels of glucose 
and other nutrients by secreting insulin. They sense blood 
nutrient levels not by using a classical receptor-signaling 
system, but by detecting the products of nutrient metabolism. 
Mutations in this pathway can cause diabetes or hypoglycemia. 
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Introduction 
All vertebrates use insulin-producing pancreatic p-cells to 
provide fuel homeostasis [l]. These cells keep track, 
minute by minute, of the levels of the predominant small 
nutrient molecules in the blood by accurately measuring 
the concentrations of glucose, amino acids and fatty acids. 
They respond to fluctuations in the levels of these sub- 
stances by secreting insulin, controlling the rate of the 
secretion so that each of the nutrients is maintained at its 
optimal level [Z]. The role of the pancreatic p-cells in fuel 
homeostasis is thus analogous to that of the thermostat in 
heating and cooling systems. 
The feedback loop of fuel homeostasis is completed by the 
insulin receptors in liver, muscle and adipose tissue that 
control fuel removal from the blood and, of course, by the 
regulated parameters of glucose, amino acids and fatty 
acids. In humans in the resting condition, these nutrient 
levels are -5 m M  for glucose, -3.5 m M  for the physiological 
mixture of 20 amino acids and -0.3mM for fatty acids. 
These levels refer to the postabsorptive situation, 8-12 h 
after a mixed meal containing carbohydrates, fats and pro- 
teins. Not surprisingly, blood fuel levels might be very dif- 
ferent shortly after ingestion of a meal(postprandially) or 
after fasts of longer duration than 12 h [3]. Postprandially, 
most levels of blood fuel molecules can be expected to be 
higher than the values listed above; after starvation, the 
levels of certain amino acids and fatty acids are also ele- 
vated, due to mobilization of these fuels from muscle and 
adipose tissue, but blood glucose levels drop to about 
4mM. The pancreatic p-cells must distinguish between 
these different nutritional situations and release insulin in 
response to the meal but not the fast. In this brief review 
we discuss the biochemical mechanisms that enable the 
pancreatic p-cell to respond optimally to physiological fluc- 
tuations in the levels of nutrients in the blood, and describe 
some of the defects in these processes that can result in 
diabetes mellitus (the most common metabolic and 
endocrine disease afflicting several hundred million people 
worldwide) or less prevalent conditions of hypoglycemia. 
The biochemical basis of fuel sensing 
The biochemical engineering of the pancreatic p-cells 
uniquely equips them to operate as the body’s fuelstat [Z]. 
One might have imagined that these fuelstat cells might 
contain specific nutrient receptors that would recognize 
and measure the levels of small nutrient molecules includ- 
ing glucose, palmitic acid and the different physiologically 
important amino acids, and that this sensing system might 
be coupled to insulin secretion by one or more of the well 
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The metabolic wheel of insulin release from P-cells. Insulin release is 
stimulated by small nutrient molecules. G, glucose; AA, amino acids; 
FA, fatty acids; the subscripts o and i refer to outside and inside the 
cell, respectively. 
known intracellular signaling pathways involving second 
messengers such as CAMP and Ca2+. Such mechanisms are 
known to operate for the other chemical senses of smell 
and taste [4]. But the fuel-sensing system of p-cells uses a 
quite different principle. Nutrient sensing relies entirely 
on nutrient metabolism: special intracellular metabolic cou- 
pling factors detect the intermediary metabolism of nutri- 
ent stimuli and link it to the second messenger systems 
that are universally employed in biological systems (Fig. 1). 
Here, we describe the signaling pathways for glucose, 
amino acids and fatty acids as stimulants of insulin release. 
Glucokinase, the p-cell glucose sensor 
Blood glucose is the most effective stimulus of insulin 
secretion [Z]. When levels of blood glucose increase, 
hormone secretion is enhanced with a characteristic depen- 
dency on the blood sugar level. The threshold for stimula- 
tion is -5 mM. Secretion reaches half maximal efficiency at 
-1OmM and is maximal at ZO-30mM. Physiological blood 
sugar levels rarely rise above 7.5mM, however. Pancreatic 
p-cells have very effective facilitated membrane transport 
systems for glucose, so intracellular and extracellular 
glucose levels rapidly.equilibrate [Z]. Thus, the intracellu- 
lar glucose level, which determines the rate of glucose 
metabolism that is required to stimulate insulin release, is a 
reliable indicator of the extracellular glucose level. The 
glucose-phosphorylating enzyme glucokinase (also termed 
hexokinase D), which phosphorylates glucose on C6, is 
central to the process of glucose metabolism in pancreatic 
p-cells. The kinetic characteristics of the enzyme explain 
how the concentration of glucose controls the rate of 
glucose phosphorylation, glycolysis and - to a considerable 
extent - glucose oxidation. 
Biochemistry of glucokinase 
Glucokinase is a 50 kDa monomeric hexokinase that phos- 
phorylates the D-forms of glucose, mannose, glucosamine 
and fructose with different kinetics for each sugar. Because 
D-glucose is the preferred physiological substrate of the 
enzyme and because of the enzyme’s characteristic low 
affinity for glucose, it is conventionally called glucokinase 
to differentiate it from other hexokinases which have 
much higher affinities for these six carbon sugars. The 
level for the half saturation of glucokinase with D-glucose 
(S,,) is 6-12mM [Z]. The rate constant k,,, at 37°C for 
glucose is about loos-1 and the high Hill number for 
glucose, 1.8, indicates that the enzyme functions coopera- 
tively. Remarkably, the enzyme does not show feedback 
inhibition by its product, glucose-6-phosphate. In liver, 
glucokinase activity is modified by a protein (the gluco- 
kinase regulatory protein, GRP) but this is probably not 
significant in pancreatic p-cells. Stearyl-CoA and palmityl- 
CoA also inhibit the enzyme competitively with glucose, 
with very low Ki values (l-2pM). These are the only 
glucokinase inhibitors known to be important in p-cells. 
Glucokinase has been found in p-cells, in liver cells and in 
some neurons of the central nervous system. In p-cells, 
the enzyme is inducible by glucose by translational or 
post-translational control mechanisms. There is consider- 
able support for the idea that high glucose stabilizes the 
enzyme and thereby decreases its turnover and raises its 
tissue level. In contrast, in the liver, glucokinase is 
induced by insulin through increased transcription. In 
pancreatic p-cells, the enzyme governs the rate of glycoly- 
sis so strongly that glycolysis changes in direct proportion 
with changes in the enzyme content of the cells. Gluco- 
kinase thus absolutely controls glycolysis in these cells. 
Because the rate of glucose metabolism in turn controls 
insulin secretion, it has been suggested that glucokinase is 
the glucose sensor of the p-cell. 
Effects of glucokinase deficiency 
The hypothesis that glucokinase functions as a glucose 
sensor has been strongly supported by clinical findings in 
humans [5] and by extensive work with transgenic animals 
[6]. Patients with a dominantly inherited familial form of 
diabetes mellitus (MODY II) were found to have muta- 
tions in one of the glucokinase alleles. Those mutations 
have been shown to increase the S,, for glucose, lower the 
k,,, or decrease the stability of the enzyme [2,7]. From 
these and other observations, one can conclude that the 
functional p-cell glucokinase of these MODY II patients 
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Figure 2 
The control of glucose-induced insulin release 
by glucokinase. Graded inhibition by 
mannoheptulose (MH) causes a graded block 
of insulin release from pancreatic islets. The Ki 
of MH for glucokinase is about 1 mM. 
Symbols indicate experimental data and 
continuous curves represent the results of 
model calculations [71. 
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may be reduced to -50% of normal, which is sufficient to 
explain their impaired insulin secretion and mildly dia- 
betic phenotype. Mice with a specific knockout of p-cell 
glucokinase become severely diabetic and die quickly 
after birth whereas transgenic mice that retain one normal 
glucokinase allele are mildly diabetic, resembling patients 
with MODY II [6]. All proven MODY II patients are 
heterozygotic, with one wild-type and one mutant gluco- 
kinase allele, implying that homozygocity is lethal in 
humans. The control of glucose-stimulated insulin release 
by glucokinase is most impressively demonstrated by a 
model experiment with isolated perifused islets from the 
pancreas [B]. Using mannoheptulose - a specific inhibitor 
of glucokinase - it can be demonstrated that reduction of 
phosphorylation by less than 20% causes a predictable 
reduction in glucose-stimulated insulin release (Fig. Z), 
similar to that seen in MODY II patients. This shows the 
importance of glucokinase in controlling the response of 
the P-cell to glucose. 
The biochemical basis of metabolic coupling 
How is the increase in glucose metabolism coupled to 
insulin release? Increased glucose phosphorylation 
enhances glycolysis, glucose oxidation and respiration and, 
by extrapolation, should increase the rate of ATP genera- 
tion in stimulated p-cells (Fig. 3a). The channeling of 
glucose through the catabolic pathways is facilitated by 
the fact that there are practically no synthetic pathways in 
p-cells that might syphon off glucose metabolites. For 
example, glycogen and fatty acid synthesis, which are 
important pathways in liver cells, are virtually absent in 
p-cells. Furthermore, p-cells have low levels of lactate 
dehydrogenase so the amount of lactate generated by gly- 
colysis is minor compared with the amounts in muscle and 
brain cells. The NADH that is generated during glycolysis 
is oxidized nearly quantitatively by mitochondrial hydro- 
gen shuttles and a fraction of the pyruvate is degraded in 
the citric-acid cycle, generating increased ATP levels 
[9,10]. These processes explain the enhanced respiration 
that is observed when pancreatic islet tissue is exposed to 
high glucose levels. 
Channel activation 
The increased ATP production that results from the 
increased metabolism of glucose alters the phosphate 
potential by’ increasing the ATP:ADP ratio of the p-cell 
cytosol. This change is recognized by adenine-nucleotide- 
sensitive K+ channels of the p-cell membrane. ATP4 
inhibits and MgADP- activates the channel; thus an 
increase in the ATP:ADP ratio leads to inhibition of the 
channel and depolarization of the p-cell membrane. This 
depolarization opens voltage-sensitive calcium channels 
and elevates intracellular Ca 2+, the most important second 
messenger. The increased levels of free cytosolic Caz+ in 
turn cause insulin release from stored insulin-containing 
granules, and this is enhanced by the activation of protein 
kinases A and C (see below). The biochemical basis of the 
exocytosis of insulin granules is currently the target of 
intensive research efforts [ 111. 
The crucial role of adenine-nucleotide-regulated potassium 
channels has been underscored by studies of the molecular 
genetics of a particular form of familial hypoglycemia 
[l&13]. Infant patients afflicted by this disorder were found 
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Figure 3 
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Metabolic coupling in nutrient stimulation of 
pancreatic @cells. (a) The pathway for the 
generation of ATP and (b) the pathway for 
generating lipid-related coupling factors. The 
following abbreviations are used: a-GP, 
ol-glycero-P; CPT, carnitine palmityl-CoA 
transferase; DAG, diacylglycerol; DHAP, 
dihydroxyacetone-phosphate; FA, fatty acids; 
GK, glucokinase; HK, hexokinase; H6P, 
hexose-6-phosphate; OAA, oxalacetic acid; 
PC, pyruvate carboxylase; PDH, pyruvate 
dehydrogenase; PFK, 6-phosphofructokinase; 
PK, pyruvate kinase; PKC, protein kinase C. 
Other abbreviations are self explanatory. 
(From [2].) 
to have mutations of a protein modifier of the potassium 
channel called the sulfonyl urea receptor (SUR) which 
results in persistent inhibition of the channel, concomitant 
membrane depolarization and insulin hypersecretion. 
Lipid signaling molecules 
The pathway of glucose metabolism outlined above also 
leads to the generation of other metabolic coupling factors 
in addition to ATP (Fig. 3b). Most important among these 
proposed coupling factors are lipid-related molecules such 
as malonyl-CoA, palmityl-CoA and stearyl-CoA [Z]. 
Malonyl-CoA is derived from citrate via the citrate lyase 
and acetyl-CoA carboxylase reactions. It inhibits carnitine 
palmityl transferase, a critical step of fatty-acid oxidation, 
and therefore causes acyl-CoA to accumulate in the cytosol. 
Acyl-CoA activates protein kinase C in a Ca*+-dependent 
manner both directly and indirectly (after conversion to 
diacylglycerol), and therefore enhances insulin secretion. 
Amino acids and fatty acids as fuel stimuli 
The amino acids and fatty acids that are derived from a 
mixed meal have been shown to stimulate insulin release 
in humans [14]. Amino acids and fatty acids are‘glucose- 
dependent secretory stimuli; unlike glucose, they cannot 
by themselves cause insulin secretion [Z]. These nutrients 
can only act as insulin secretagogues when the level of 
glucose is higher than 5 mM. This makes sense, because it 
allows them to be mobilized from muscle and adipose 
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tissue during starvation, when blood glucose levels are 
low. In this circumstance, insulin secretion ceases and 
glucose levels are then maintained by hepatic gluconeo- 
genesis, which produces glucose from specific amino acids 
and lipid-derived glycerol. 
Amino acid transport and deamination 
How do amino acids and fatty acids cause insulin release? 
Amino acids can be assumed to be transported into the 
B-cells by several transporters that are well characterized 
in other tissues and probably present in p-cells. Most 
of them are then likely to be transaminated by a family 
of pyridoxal-P-dependent enzymes that transfer the 
amino group to a-ketoglutarate to form glutamate [15]. 
The carbon skeletons of the amino acids are converted 
to pyruvate, acetyl-CoA, a-ketoglutarate, succinyl-CoA, 
fumarate and oxalacetate, and provide substrates for the 
citric-acid cycle. Glutamate serves as the predominant 
final product of the transamination reactions and is oxida- 
tively deaminated, a process termed transdeamination 
(Fig. 4). For the system to operate it is necessary that 
at least one product of the citric-acid cycle (preferably 
the final product) be removed continuously. One way 
this is accomplished is to convert malate to pyruvate via 
the oxidative malic enzyme reaction (i.e. malate + NADP+ 
u pyruvate + NADPH+ + H+ + CO,). This allows most of 
the amino acids to be metabolized to CO,, H,O and 
NH,+. Amino acid degradation is hypothesized to gener- 
ate the same coupling factors that are derived from 
glucose metabolism, ATP and malonyl-CoA. 
In the normal pancreatic p-cell the critical reaction of 
transdeamination, catalyzed by glutamate dehydrogenase 
(GDH), appears to be far from equilibrium so that oxida- 
tion of glutamate is largely inhibited. Thus, little ATP 
and malonyl-CoA would be generated from amino acids, 
explaining the lack of response when amino acids are 
present in the absence of glucose. High levels of GTP 
and low levels of free ADP may be responsible for this 
inhibition but other factors, so far unknown, may also be 
important. The stimulation of insulin release by amino 
acids in the presence of glucose may be due to enhanced 
production of pyruvate, o-ketoglutarate and oxalacetate 
that would result from even a small increase in glucose 
metabolism. These metabolites can act as acceptors for 
the transamination reaction, and should therefore 
enhance the degradation of amino acids, allowing them to 
potentiate the stimulatory effect of glucose. Evidence for 
this view comes from experiments using artificial stimula- 
tors of glutamate dehydrogenase [16], which, under 
certain conditions, cause insulin release in the absence 
of glucose. 
The importance of the GDH-catalyzed reaction in the 
amino-acid-stimulated release of insulin is supported by 
the biochemical and genetic elucidation of a hypoglycemia 
Figure 4 
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The transdeamination of amino acids. TA, transaminases; GDH, 
glutamate dehydrogenase. Transamination reactions occur in the 
cytosol and oxidative glutamate deamination takes place in the 
mitochondrial matrix. The a-ketoacid products of the transamination 
reaction are catabolized further by the diverse pathways of amino acid 
metabolism. Glutamate and a-ketoglutarate (in addition to other 
transport metabolites) are shuttled back and forth across the 
mitochondrial membrane. 
syndrome associated with hyperinsulinemia and mild hyper- 
ammonemia (C. Stanley, Children’s Hospital of Philadel- 
phia, personal communication). Infant patients afflicted by 
this disease have mutations of GDH, such that the 
inhibition of the enzyme by GTP or its activation by ADP 
are reduced or enhanced, respectively. Stanley proposes 
that in these patients the GDH reaction tends toward equi- 
librium, resulting in increased glutamate oxidation and 
generation of metabolic coupling factors even when 
glucose levels are low. 
A large body of experimental and clinical evidence suggests 
that regulation of GDH in pancreatic p-cells is critically 
important for amino-acid-stimulated insulin release and 
that the enzyme is probably activated only when the blood 
sugar falls below critical levels [17]. Leucine is particularly 
effective in this regard. This would explain the leucine 
hypersensitivity that has been observed in hypoglycemia 
patients. Removal of the negative control of the enzyme 
by genetic mutation, in transformed p-cells or by phar- 
macological intervention may cause insulin hypersecretion 
and hypoglycemia. 
Fatty acids as insulin secretagogues 
Fatty acids can also trigger the glucose-dependent secre- 
tion of insulin [2,18]. Again, it makes sense that this 
response should be glucose dependent, as this ensures 
that the physiological surge of free fatty acids that occurs 
during starvation is not perceived as a stimulus for insulin 
release. Under some circumstances, high levels of fatty 
acids may also inhibit the glucokinase glucose sensor 
because acyl-CoA, the first metabolite in fatty acid catabo- 
lism, is a very potent inhibitor of this enzyme [‘Z]. But this 
inhibition is competitive with glucose, and is therefore 
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significant only when glucose levels are < 5 mM. If glucose 
levels are high (-7SmM), as seen after a mixed meal, 
fatty acids can stimulate insulin release. 
Several different metabolic coupling factors have been 
considered to be involved in the insulin response to fatty 
acids [Z]. First, ATP production is probably increased. 
Second, as acyl-CoA and diacylglycerol are generated from 
fatty acids in the presence of high glucose, protein 
kinase C may be activated (Fig. 3b). Some investigators 
have suggested that the activation of protein kinase C is 
essential for glucose-stimulated insulin release, not just a 
contributory factor [19]. When the generation of acyl-CoA 
and diacylglycerol is blocked by hydroxycitrate (an 
inhibitor of the cytosolic enzyme citrate lyase that cleaves 
citrate to acetyl-CoA and oxalacetate; see Fig. 3b), insulin 
release is also blocked, supporting this view. Palmitic acid 
was found to overcome the effect of this enzyme inhibitor 
on glucose-stimulated insulin release. 
General hypothesis of fuel-induced insulin 
release 
The simplest general hypothesis of fuel-stimulated 
insulin release envisions that ATP serves as the essential 
general metabolic coupling factor that is generated by the 
activation of intermediary metabolism. Malonyl-CoA acts 
as a secondary stimulus by producing acyl-CoA and 
diacylglycerol, which may potentiate the effect of ATP 
depending on the nature of the stimulus. Glucose is 
required for amino-acid stimulation of insulin release 
because it is needed to provide a-keto acids as substrates 
for transaminations. In the case of fatty acids, glucose is 
needed to redirect lipid metabolism from degradation to 
the synthesis of lipid-related coupling factors. 
There is increasing evidence that this may not be the whole 
story, however. It has recently been suggested that cyclic 
ADP-ribose and diadenosine polyphosphate (DAPP) can 
both function as metabolic coupling factors [20,21]. Cyclic 
ADP-ribose is thought to mobilize CaZ+ from intracellular 
stores, and DAPP is proposed to block the K+-channel in a 
similar way to ATP during glucose stimulation. Much work 
is needed to fully assess the relative contribution of any 
of the proposed signaling pathways involving metabolic 
coupling factors. 
Expanding the m inimal model 
So far, we have sketched a minimal model of fuel-stim- 
ulated insulin release (summarized in Figure 3a,b). 
There are at least two subsidiary hypotheses that need 
to be presented to do justice to current research in this 
field. One is the proposal that metabolic oscillations are 
essential for glucose-stimulated release and, by extrapo- 
lation, any fuel-stimulated release of insulin [22,23] and 
the other is the contention that p-cells are unable to 
respond to fuel, including glucose, on their own without 
priming by hormones or neurotransmitters [‘24]. These 
two hypotheses are discussed below. 
Metabolic oscillations - an absolute requirement? 
There is no doubt that single p-cells and isolated islets can 
respond in an oscillatory manner to high blood glucose 
levels. This response pattern is most distinctly observed 
by microscopic Ca*+ imaging of isolated perifused mouse 
islets stimulated with moderately high glucose levels 
(Fig. 5). The Ca2+ oscillations are paralleled by oscillatory 
patterns of insulin release. This can be demonstrated using 
microperifusion and very sensitive assays for insulin [2.5]. 
Some investigators believe that these oscillations are pri- 
marily an expression of metabolic oscillations resulting 
from flux control by phosphofructokinase (PFK), which 
serves as a pulse generator for the glycolytic pathway [Z?]. 
It has been shown that islet tissue contains the muscle 
isoform of PFK; this has kinetic characteristics that allow 
it to serve as a pulse generator [26]. Most importantly, 
PFK can be activated by its substrate fructose-1,6-bis- 
phosphate (F-6-P) and by its product, F-1,6-P, and its 
activity can also be positively modified by ADP and nega- 
tively modified by ATP. Computer modeling has shown 
that oscillations in Ca2+ concentration may indeed be gen- 
erated through changes in PFK activity controlled as 
described above [23]. There is also some experimental 
evidence to support such a role for PFK [ZZ]. In an oscilla- 
tory system, the effects of the periodic changes in the 
levels of the coupling factors ATP and ADP will be 
greatly magnified, because the ratio of ATP to ADP 
reaches the threshold level for triggering insulin release in 
a pulsatile manner. 
If PFK is the metabolic pulse generator that explains the 
oscillatory response seen for simple cells, intact pancreatic 
islets and groups of islets, then one must conclude that 
intra-islet-signaling and inter-islet-signaling systems exist 
to synchronize the oscillations. It has been suggested that 
insulin itself may serve as this signal and a mathematical 
model has been proposed describing how such a system 
might operate [27]. 
There is some clinical evidence against this hypothesis, 
however. Genetic defects of muscle PFK are seen in 
Tarui’s disease, a form of glycogen storage disease, but 
these defects do not lead to diabetes in humans [28] or 
dogs [29], as would be expected if the metabolic oscilla- 
tions suggested to be caused by PFK are essential for 
insulin release. But it is not yet clear whether patients and 
animals that lack PFK show pulsatile insulin release. If 
they do, we propose that it is plausible to assume that the 
oscillatory release pattern observed in the intact organism 
is governed by the nervous system [30] or by complex 
endocrine feedback loops [27] rather than by primary 
metabolic events of the p-cells governed by PFK. 
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Figure 5 
Synchronized oscillations of calcium in p-cells 
of the isolated perifused mouse islet 
stimulated with glucose. Signals of Fura-P- 
loaded islets were recorded from four 
quadrants of the islet image. The lower panel 
shows the records obtained at two wave 
lengths (green at 334 nm and red at 380 nm) 
and the upper panel shows the Ca2+ levels 
calculated from the ratio recording data of 
four defined islet areas (in different colors). 
The glucose level was 4 mM during 
preperifusion and 12 mM during stimulation. 
Duration of perifusion (s) 
Neural and endocrine regulation of insulin release 
It is well established that fuel-stimulated insulin release 
can be markedly influenced by neural and endocrine 
factors [31]. Acetylcholine, the neurotransmitter of the 
vagus, strongly potentiates glucose-stimulated insulin 
release, but is not effective in the absence of glucose. In 
contrast, the catecholamines adrenaline and noradrenaline 
block stimulated insulin release. Muscarinic and o-adren- 
ergic receptors mediate these effects of the parasympa- 
thetic and sympathetic nervous systems. The biochemical 
signaling pathways involved in this neuroendocrine modu- 
lation of p-cells are, in general, similar to those in 
other organs. 
The secretory response of p-cells to fuel stimulation is also 
markedly enhanced by the gut hormone glucagon-like 
peptide 1 (GLP-1) [24], a member of the glucagon family, 
which is released into the portal circulation when a meal is 
digested. The physiological importance of GLP-1 is strik- 
ingly demonstrated by comparing the stimulatory effica- 
cies of equivalent glucose loads given orally (which 
induces GLP-1) or intravenously (which does not). 
Ingested glucose is significantly more effective. Several 
investigators have gone so far as to suggest that priming by 
enteric hormones (GLP-1) and/or neural stimulation (vagal 
acetylcholine) are absolutely necessary for fuels, particu- 
larly glucose, to be effective stimuli, suggesting that p-cells 
are not intrinsically competent as fuel-sensor cells [24]. 
At least two sets of observations contradict this concept, 
however. First, a significant fraction of isolated single 
p-cells studied electrophysiologically, optically and by 
other approaches show characteristic electrical, ‘ionic and 
secretory responses when stimulated with high glucose in 
the absence of neuroendocrine factors, clearly demonstrat- 
ing their competency [32,33]. Second, various cultured 
p-cell lines respond to fuels including glucose, amino 
acids and fatty acids, without prior priming by neurotrans- 
mitters and hormones. We therefore continue to believe 
that considerable subpopulations of p-cells are able to 
respond to glucose directly, that it is glucose that enables 
p-cells to respond to other fuels (amino acids and fatty 
acids), and that the role of transmitters of the autonomic 
nervous system and enteric hormones is to potentiate or 
curb the action of fuel molecules, depending on the 
momentary need of the organism. 
Inter-P-cell signaling 
A second version of the competency hypothesis states that 
many p-cells require cell-to-cell contact to respond to fuel 
stimulation [33]. In this view, only a subpopulation of 
p-cells are intrinsically competent, and the rest require 
cell-to-cell contact to achieve the full potential of their 
insulin secretory response. This view receives some 
support from experimental evidence that shows a tight 
synchronization of the pulsatile electrical, ionic and secre- 
tory events of thousands of p-cells that constitute a single 
islet organ (Fig. 5). The synchronization is clearly shown 
by the microscopic imaging of free Ca*+ transients after 
stimulation with glucose. Caz+ signals recorded from cir- 
cumscribed separate areas within an islet show a tight syn- 
chronization of oscillations. This phenomenon is highly 
reproducible in isolated mouse islets, and has also been 
described for isolated human islets but is not readily 
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demonstrated in islets from rats. The intracellular free 
Ca2+ oscillations or waves have a frequency of about one 
cycle min-’ at 12mM glucose. Complementary data show 
that low molecular fluorescent dyes injected into a p-cell 
spread to microdomains of surrounding p-cells and also 
that the size of the fields of interconnected cells is greatly 
increased when glucose levels are high [33]. 
The structural basis of this phenomenon is found in the 
form of gap-junctional complexes consisting of the con- 
nexin-43 protein which has been intensively studied with 
the electron microscope and by molecular genetic 
approaches [33]. The existence of a syncytial arrangement 
and of synchronization of the secretory responses of cells 
suggests that recruitment of cells might be necessary so 
that the threshold for stimulation may be more clearly 
defined and the dose-response curve can be steeper than 
possible with the population of disconnected cells. This 
implies that the thresholds and dose-response curves of 
individual cells differ widely, which is consistent with 
experimental data. 
It has been suggested that the oscillatory patterns seen in 
single islets, whatever their origins, are the basis for the 
much slower pulsations of insulin release from the intact 
pancreas into the circulation as observed in humans [34]. 
This is plausible only if all islets are coupled to each other 
through a comprehensive signaling network that synchro- 
nizes the oscillations. Such a network is best conceptual- 
ized as neural or hormonal in nature but it remains to be 
discovered and characterized. 
Hyperglycemia, hypoglycemia and chemistry 
Diabetes mellitus (hyperglycemia) is a disease that afflicts 
several hundred million people worldwide and causes 
severe morbidity and increased mortality; hypoglycemia 
syndromes, although relatively rare, are hard to manage 
clinically. Most of the diabetes syndromes have a genetic 
basis but less than 5% of the genetic defects have been 
found so far. Examples of defects found in p-cells include 
mutations of the insulin gene, of the glucokinase glucose 
sensor gene and of various transcription factors; examples 
outside the P-cell include defects in the insulin receptor 
that regulates fuel metabolism of muscle, liver and 
adipose tissue. Genetic causes of some of the hypo- 
glycemia syndromes have also been identified. In the 
hypersecreting p-cells, mutations of proteins that are asso- 
ciated with ion channels and mutations of control steps of 
intermediary metabolism explain the disease. Hypo- 
glycemia syndromes may also arise from mutations of 
various enzymes of intermediary metabolism unrelated to 
islet-cell function. 
In most of the characterized diabetes mellitus and hypo- 
glycemia syndromes, the pancreatic P-cells are pro- 
foundly involved. As outlined here, our understanding of 
the striking biochemical design features of the pancreatic 
p-cell has advanced dramatically during the past two 
decades, making it possible to evolve a plausible general 
concept of islet-cell function. Many reliable and sophisti- 
cated experimental systems are now available to study 
p-cell function. The stage is thus set for pharmaceutical 
chemists and pharmacologists to use this new information 
and technology to attempt to discover chemical com- 
pounds that might prevent or remedy some of the 
recently elucidated p-cell defects. The pancreatic p-cell 
should therefore be a major target of the pharmaceutical 
chemical industry. 
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